| Literature DB >> 36078780 |
Shensheng Ni1,2, Chunyu Li1,2, Yicheng Yu3, Dongze Niu1,2, Jie Zhu2, Dongmin Yin1,2, Chongqing Wang4, Wenfan Zhang1,2, Xingmei Jiang5, Jianjun Ren1,2.
Abstract
Erythromycin is one of the most commonly used macrolide antibiotics. However, its pollution of the ecosystem is a significant risk to human health worldwide. Currently, there are no effective and environmentally friendly methods to resolve this issue. Although erythromycin esterase B (EreB) specifically degrades erythromycin, its non-recyclability and fragility limit the large-scale application of this enzyme. In this work, palygorskite was selected as a carrier for enzyme immobilization. The enzyme was attached to palygorskite via a crosslinking reaction to construct an effective erythromycin-degradation material (i.e., EreB@modified palygorskite), which was characterized using FT-IR, SEM, XRD, and Brunauer-Emmett-Teller techniques. The results suggested the successful modification of the material and the loading of the enzyme. The immobilized enzyme had a higher stability over varying temperatures (25-65 °C) and pH values (6.5-10.0) than the free enzyme, and the maximum rate of reaction (Vmax) and the turnover number (kcat) of the enzyme increased to 0.01 mM min-1 and 169 min-1, respectively, according to the enzyme-kinetics measurements. The EreB@modified palygorskite maintained about 45% of its activity after 10 cycles, and degraded erythromycin in polluted water to 20 mg L-1 within 300 min. These results indicate that EreB could serve as an effective immobilizing carrier for erythromycin degradation at the industrial scale.Entities:
Keywords: EreB; erythromycin degradation; immobilization; palygorskite
Mesh:
Substances:
Year: 2022 PMID: 36078780 PMCID: PMC9518184 DOI: 10.3390/ijerph191711064
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Preparation of purified EreB: (a) agarose gel electrophoresis: Lane 1: empty plasmid of E. coli; Lane 2: recombinant E. coli; (b) SDS-PAGE electrophoresis: Lane 1: supernatant of the EreB-expressing cells; Lane 2: sediment of the EreB-expressing cells; Lane 3: empty plasmid of E. coli; (c) Lane 1: supernatant of the EreB-expressing cells; Lane 2: purified enzyme; Lane 3: empty plasmid of E. coli.
Figure 2Optimization of: (a) enzyme loading, (b) crosslinker concentration, and (c) temperature.
Figure 3Scanning electron micrographs of: (a) palygorskite (10,000×), (b) modified palygorskite (10,000×), and (c) EreB@modified palygorskite (30,000×).
Figure 4(a) Fourier-transform-infrared spectra of palygorskite (black), modified palygorskite (red), and EreB@modified palygorskite (blue). (b) X-ray-diffraction patterns of palygorskite (black), modified palygorskite (red), EreB@modified palygorskite (blue), and crude protein lyophilized powder.
Figure 5Brunauer–Emmett–Teller analysis of: (a) palygorskite, (b) modified palygorskite, and (c) EreB@modified palygorskite.
Figure 6Characterization of the enzymatic properties of free EreB and EreB@modified palygorskite. Effects of: (a) temperature and (b) pH on the relative activity at their own optimal pH (8.0) and temperature (45 °C), respectively. (c) Kinetic analysis of free EreB and immobilized EreB. (d) Recycling performance of EreB@modified palygorskite. The letters above different columns addressed not by the same letter are significantly different according to student’s t test, (p < 0.01).
Comparison of kinetic parameters of free and immobilized EreB.
| Catalyst | KM (mM) | Vmax (mM min−1) | kcat (min−1) | kcat/KM (min−1 mM−1) |
|---|---|---|---|---|
| Free EreB | 438.49 | 0.11 | 1202.75 | 2.74 |
| Immobilized EreB | 1129.04 | 0.12 | 1371.21 | 1.21 |
Figure 7Degradation performance of EreB@modified palygorskite in erythromycin-polluted wastewater containing 50 and 100 mg·L−1 erythromycin.